Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer.
about
Mouse models of prostate cancer.An experimental study on cervix cancer with combination of HSV-TK/GCV suicide gene therapy system and 60Co radiotherapy.The Current Status of Gene Therapy for Prostate Cancer.Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease.Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.In situ gene therapy for prostate cancer: immunomodulatory approaches.Proposed mechanisms of action for prostate cancer vaccines.Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.Ovine atadenovirus: a review of its biology, biosafety profile and application as a gene delivery vector.Enhanced central memory cluster of differentiation 8(+) and tumor antigen-specific T cells in prostate cancer patients receiving repeated in situ adenovirus-mediated suicide gene therapy.Gene therapy in urology: strategies to translate theory into practice.Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer.Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development.Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant gliomaMurine dendritic cells modified with CXCL10 gene and tumour cell lysate mediate potent antitumour immune responses in mice.Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses.Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.Eradication of murine mammary adenocarcinoma through HSVtk expression directed by the glucose-starvation inducible grp78 promoter.Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.Current status of gene therapy for prostate and bladder cancer.Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma.Transcription-targeted gene therapy for androgen-independent prostate cancer.A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models.Transrectal gene therapy of the prostate in the canine model.The role of herpes simplex virus thymidine kinase in the treatment of solid tumours.Biomarker distribution after injection into the canine prostate: implications for gene therapy.Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.Transrectal ultrasound for monitoring murine orthotopic prostate tumor.
P2860
Q33739296-E74932EC-4C25-47FD-9936-FEA40191280AQ33740015-C9F72704-4914-468C-B320-AB39E5EF1FB2Q33889283-1443B9F6-1C2F-4457-8862-118EC2693CEAQ33947221-3E5CC7DE-9A73-4063-B847-5A6630E39372Q34208293-3A4BBBF4-F968-4ABC-988C-C246B8C1A8D0Q34452001-54A3E603-3AAC-45DD-B048-0256D12559F1Q35174754-315DBEEE-8026-4951-A33E-C0E4DBDA0696Q35625500-898BDBAE-7979-4926-8E31-BD1F2E583531Q35734124-EF4B9481-3D6C-49DD-9B83-7AFF7A7A5261Q35753616-E054AC3C-062E-412E-9423-581BE6E4C792Q36312228-CD227AFD-35E6-4660-A832-3E8F6F03D143Q37347492-830BA696-57EF-4BC1-93FC-364129A24BA8Q37861631-6F4343CF-FA85-4CA4-8CFB-17F8EFD8F2E4Q38912327-CC06EC99-624C-47E7-B9C7-98CA51944000Q40185066-5928B6EC-6987-44F5-AD03-EBD68E3DC45FQ40392477-2F89D6DB-AFFD-4A5C-9545-F444E0EC8445Q40632608-69A4AB18-F23B-4304-8522-624AF65A1796Q40665345-6EFB195D-1662-47EE-91D4-8074F92FAABFQ40888646-0A8069D0-AD56-4634-B437-13141591ACB2Q40937528-5591E15C-2D45-49D9-A171-2F189BE794B9Q41631041-C5C52C28-BC20-43E8-B781-1EDB50A054AEQ42153454-F9CBF2FF-4B91-45EC-9823-DCEE10AF7AF6Q43169344-E3113FBF-AB6E-491A-B946-58485E49881EQ43955932-774F30B3-960A-4D5B-A433-D75DF28AA9B6Q44012459-158E50BE-1A40-4A55-AC7E-EFAFDC1E9CB4Q44047798-E4C4BBEB-C416-4D8C-837A-215719E7C1DEQ44113154-BDD700F5-A932-4B4F-AF81-94A313D2A7C3Q45873140-B1461D31-6183-477A-B529-46FD96533F32Q45885542-7C1552A9-2D10-4C79-861D-DF24194B2DC4Q51358444-7E374F31-A524-45EC-87C8-ACEB64DE4E79
P2860
Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Adenovirus-mediated herpes sim ...... ouse model of prostate cancer.
@en
type
label
Adenovirus-mediated herpes sim ...... ouse model of prostate cancer.
@en
prefLabel
Adenovirus-mediated herpes sim ...... ouse model of prostate cancer.
@en
P2093
P1476
Adenovirus-mediated herpes sim ...... ouse model of prostate cancer.
@en
P2093
P304
P356
10.1002/(SICI)1097-0215(19970117)70:2<183::AID-IJC8>3.0.CO;2-T
P577
1997-01-01T00:00:00Z